Health professionals are encouraged to take the Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …

Health professionals are encouraged to take the ESC Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …

Antiplatelet agents and anticoagulants are a mainstay for the prevention and treatment of
thrombosis. However, despite advances in antithrombotic therapy, a fundamental challenge …

Although cardiologists have long treated patients with coronary artery disease (CAD) and
concomitant type 2 diabetes mellitus (T2DM), T2DM has traditionally been considered just a …

Background: The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …

Peripheral artery disease is an atherosclerotic disease of the lower extremities associated
with high cardiovascular mortality. Management of this condition may include lifestyle …

Patients with known cardiovascular disease who have not had a recent acute event are
often referred to as having stable coronary artery disease (CAD). The concept of 'stable'CAD …

Coronary heart disease is a chronic, systemic disease with a wide range of associated
symptoms, clinical outcomes, and health care expenditure. Adverse events from coronary …

Background: Patients with established coronary artery disease or peripheral artery disease
often have diabetes mellitus. These patients are at high risk of future vascular events …

Advances in antiplatelet therapies for patients with cardiovascular disease have improved
patient outcomes over time, but the challenge of balancing the risks of ischaemia and …